We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-6.57%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$151M
AUM Growth
-$4.77M
Cap. Flow
+$6.61M
Cap. Flow %
4.38%
Top 10 Hldgs %
51.89%
Holding
243
New
14
Increased
48
Reduced
40
Closed
18
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IEF icon
226
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
-176
Closed -$18K
IGPT icon
227
Invesco AI and Next Gen Software ETF
IGPT
$1.18B
-1,158
Closed -$35K
IJK icon
228
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
-327
Closed -$21K
ISTB icon
229
iShares Core 1-5 Year USD Bond ETF
ISTB
$5.12B
-232
Closed -$11K
NLY icon
230
Annaly Capital Management
NLY
$17.2B
-2,784
Closed -$66K
PBW icon
231
Invesco WilderHill Clean Energy ETF
PBW
$406M
$0 ﹤0.01%
10
PXH icon
232
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.95B
$0 ﹤0.01%
+1
New +$18
RSP icon
233
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$0 ﹤0.01%
1
TAN icon
234
Invesco Solar ETF
TAN
$1.45B
-67
Closed -$5K
VMBS icon
235
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$0 ﹤0.01%
+11
New +$524
VOX icon
236
Vanguard Communication Services ETF
VOX
$5.78B
-51
Closed -$5K
VSS icon
237
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.4B
$0 ﹤0.01%
3
TCDA
238
DELISTED
Tricida, Inc. Common Stock
TCDA
-15,000
Closed -$145K
AERI
239
DELISTED
Aerie Pharmaceuticals
AERI
-10,741
Closed -$81K
HYT.RT
240
DELISTED
BlackRock Corporate High Yield Fund, Inc. Rights (expiring October 13, 2022)
HYT.RT
$0 ﹤0.01%
+10,000
New +$57
EPZM
241
DELISTED
Epizyme, Inc
EPZM
-20,000
Closed -$29K
NBRV
242
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
-400
Closed -$2K
LJPC
243
DELISTED
La Jolla Pharmaceutical Company
LJPC
-10,000
Closed -$32K

Similar funds

Running Point Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Running Point Capital Advisors held 243 positions worth $151M, down 3.1% from $156M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Running Point Capital Advisors deployed $6.61M of net new capital in Q3 2022, opening 14 new positions and adding to 48 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.07M trimmed.

  • Running Point Capital Advisors's largest Q3 2022 buy was iShares MSCI Emerging Markets ETF: 56,382 shares worth $1.97M.
  • Running Point Capital Advisors added most to State Street SPDR Nuveen ICE High Yield Municipal Bond ETF in Q3 2022, an estimated $3.04M increase.
  • Running Point Capital Advisors's biggest Q3 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.07M.
  • Running Point Capital Advisors fully exited Boeing in Q3 2022, selling an estimated $404K.
  • Running Point Capital Advisors's ten largest holdings make up 52% of its $151M portfolio in Q3 2022.
  • Running Point Capital Advisors opened 14 new positions and closed 18 in Q3 2022.
  • Running Point Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $151M.

Based on Running Point Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.